PT758890E - Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca - Google Patents

Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca

Info

Publication number
PT758890E
PT758890E PT95918128T PT95918128T PT758890E PT 758890 E PT758890 E PT 758890E PT 95918128 T PT95918128 T PT 95918128T PT 95918128 T PT95918128 T PT 95918128T PT 758890 E PT758890 E PT 758890E
Authority
PT
Portugal
Prior art keywords
treatment
enxaqueca
antagonists
catch
inhibitors
Prior art date
Application number
PT95918128T
Other languages
English (en)
Inventor
Jes Olesen
Original Assignee
Jes Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jes Olesen filed Critical Jes Olesen
Publication of PT758890E publication Critical patent/PT758890E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
PT95918128T 1994-05-11 1995-05-10 Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca PT758890E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94610027 1994-05-11
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Publications (1)

Publication Number Publication Date
PT758890E true PT758890E (pt) 2005-06-30

Family

ID=8218183

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95918128T PT758890E (pt) 1994-05-11 1995-05-10 Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca

Country Status (12)

Country Link
US (1) US6265441B1 (pt)
EP (1) EP0758890B1 (pt)
JP (2) JPH10500129A (pt)
AT (1) ATE291909T1 (pt)
AU (1) AU704059B2 (pt)
CA (1) CA2189762C (pt)
DE (1) DE69534118T2 (pt)
DK (1) DK0758890T3 (pt)
ES (1) ES2238074T3 (pt)
PT (1) PT758890E (pt)
SI (1) SI0758890T1 (pt)
WO (1) WO1995031195A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
EP1829539A3 (en) * 1996-11-05 2008-02-20 HEADEXPLORER ApS A method for treating tension-type headache
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (en) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
PL180081B1 (pl) 1993-08-12 2000-12-29 Astra Ab Nowe pochodne amidyny i sposób ich wytwarzania PL PL PL PL PL PL PL
GB9317686D0 (en) * 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
US5807886A (en) * 1994-05-07 1998-09-15 Astra Aktiebolag Bicyclic amidine dervatives as inhibitors of nitric oxide synthetase

Also Published As

Publication number Publication date
JP2007137906A (ja) 2007-06-07
EP0758890A1 (en) 1997-02-26
AU704059B2 (en) 1999-04-15
SI0758890T1 (pt) 2005-08-31
DE69534118T2 (de) 2006-02-09
CA2189762C (en) 2009-01-13
EP0758890B1 (en) 2005-03-30
DE69534118D1 (de) 2005-05-04
ES2238074T3 (es) 2005-08-16
DK0758890T3 (da) 2005-04-18
WO1995031195A1 (en) 1995-11-23
CA2189762A1 (en) 1995-11-23
AU2417995A (en) 1995-12-05
ATE291909T1 (de) 2005-04-15
JPH10500129A (ja) 1998-01-06
US6265441B1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DE69525847T2 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
ATE217321T1 (de) Aromatische heterocyclische derivate als enzyminhibitoren
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
ATE316785T1 (de) Jak-3 hemmer zur behandlung von allergischen störungen
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
TR199801255T2 (xx) Vitronektin resept�r antagonistleri.
ATE247470T1 (de) Neue substituierte imidazolverbindungen
DK0840732T3 (da) Substituerede benzolactamforbindelser som substans P-antagonister
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
TR199800773T2 (xx) Trombin inhibit�rleri.
DE59707502D1 (de) Holzschutzmittel für den nachschutz
EA200201175A1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
PT758890E (pt) Utilizacao de agentes de captura, inibidores ou antagonistas de no no tratamento da enxaqueca
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
DE69917230D1 (de) Kombinationspräparat, das selektive nmda nr2b-antagonisten und cox-2 inhibitoren enthält
ATE234359T1 (de) Fusionsproteine bestehend aus gewebefaktor- kunitzdomäne als inhibitoren des faktors viia
BR9809848A (pt) Composição
AR028730A1 (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxis de la obesidad y utilizacion de dichos compuestos
TR199901703T2 (xx) Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi.
BR9508406A (pt) Uso de um composto e método para o tratamento e/ou profilaxia em mamíferos
SE0302361D0 (sv) Inhibering av upptagning av monoamin
NO984245L (no) Nasal administrasjon av midler for behandling av emesis med forsinket begynnelse